OTC · ETRGF
Entourage Health Corp.
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
Loading market information…
OTC · NVIVQ · USD
Stock price
Quote as of Jul 15, 2024, 05:38 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
InVivo Therapeutics Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
InVivo Therapeutics Holdings Corp. is a U.S.-based biotechnology and biomaterials company, engaged in both research and clinical development. The company's primary focus is on pioneering and commercializing biopolymer scaffolding devices specifically designed for the treatment of spinal cord injuries (SCI). Its flagship product under development is the Neuro-Spinal Scaffold implant, which is constructed from a blend of biocompatible and bioresorbable polymers. These polymers include Poly lactic-co-glycolic acid (PLGA), a material frequently found in dissolvable sutures that provides crucial biocompatible support for the scaffold, and Poly-L-Lysine, a positively charged polymer used to encourage cellular attachment. Founded in 2003, InVivo Therapeutics maintains its headquarters in Cambridge, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
$0.16$0.00 (0.0%)
RegenETP, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.93% below the high.
$0.01+$0.01 (+316.67%)
Novation Companies, Inc.: Healthcare · Medical - Care Facilities.
$0.01+$0.00 (+4.0%)
Digipath, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.14% below the high.
$0.00$0.00 (0.0%)
Nutroganics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Suvanza Pharma, LLC’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$0.10CA$0.00 (0.0%)
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.01-$0.09 (-90.0%)
Point of Care Nano-Technology, Inc.: Healthcare · Biotechnology.
